Validation

Agilent Resolve Raman Receives Multiple Recognitions for HazMat and CBRN Excellence

Retrieved on: 
Thursday, December 7, 2023
Technology, Hardware, Other Technology, Resolve, NYSE, Emergency, Risk, Radiation, Agilent Technologies, Chemical substance, Raman, Validation, CBRN, Medical imaging

Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders following independent use and evaluation by both the UK’s National CBRN Centre, and the US’ Department of Homeland Security.

Key Points: 
  • Agilent Technologies Inc. (NYSE: A) today announced that the Agilent Resolve Handheld Raman Spectrometer has been recognized for excellence as a tool for emergency responders following independent use and evaluation by both the UK’s National CBRN Centre, and the US’ Department of Homeland Security.
  • In the United Kingdom, the Resolve instrument received the National CBRN (Chemical, Biological, Radiological and Nuclear) Centre Certificate of Merit for 2023.
  • The CBRN Certificate of Merit award recognizes the value of the Resolve instrument, and the added services and responsivity Agilent provides to its customers.
  • This certificate is confirmation that all these services based in the UK recognize the benefits of the Agilent Resolve Handheld Raman Spectrometer.

Cardio Diagnostics Holdings, Inc. Announces Breakthrough in Coronary Heart Disease Detection with PrecisionCHD Test, Published in the Journal of the American Heart Association

Retrieved on: 
Monday, November 20, 2023
Other Science, Pharmaceutical, Research, Telemedicine, Virtual Medicine, Artificial Intelligence, Medical Devices, Hospitals, Genetics, Science, Technology, Clinical Trials, Medical Supplies, Cardiology, General Health, Biotechnology, Health, University, Education, Radiation, Security (finance), Entrepreneurship, Travel, Federal Medical Centres, Artificial intelligence, Cardiovascular disease, Patient, Assessment, Journal, PCR, Coronary artery disease, American Heart Association, CHD, Diagnosis, Validation, Intermountain Health, Methylation, Growth, Moyamoya disease, Hospital, Telehealth, Medical device, Medical imaging, JAHA

Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its groundbreaking study in the Journal of the American Heart Association (JAHA) , an official journal of the American Heart Association.

Key Points: 
  • Cardio Diagnostics Holdings, Inc. (Nasdaq: CDIO), a leader in artificial intelligence-driven precision cardiovascular medicine tests, today announced the publication of its groundbreaking study in the Journal of the American Heart Association (JAHA) , an official journal of the American Heart Association.
  • The article entitled "The Validation of an Integrated Genetic-Epigenetic Test for the Assessment of Coronary Heart Disease," unveils a significant leap in CHD diagnosis.
  • Furthermore, some of the tests are not sensitive to all forms of CHD and can be very costly.
  • As a result, millions of Americans do not receive adequate and potentially lifesaving cardiac care in a timely manner.

Craig Sharpe Appointed as Chief Operating Officer of The Healthcare Innovation Company and Validation Institute

Retrieved on: 
Wednesday, December 13, 2023
Organization, CPMG, Avid Technology, Validation, Growth, Management, Emerald

NEEDHAM, Mass., Dec. 13, 2023 /PRNewswire-PRWeb/ -- The Healthcare Innovation Company (thINc) and Validation Institute announce the appointment of Craig Sharpe as their new Chief Operating Officer, effective January 2, 2024. With a portfolio of more than 20 years in leadership roles within the events and technology sectors, Mr. Sharpe brings a wealth of experience and a proven track record of fostering growth through innovative strategies and operational excellence.

Key Points: 
  • NEEDHAM, Mass., Dec. 13, 2023 /PRNewswire-PRWeb/ -- The Healthcare Innovation Company (thINc) and Validation Institute announce the appointment of Craig Sharpe as their new Chief Operating Officer, effective January 2, 2024.
  • As COO, Sharpe will work closely with Vidar Jorgensen, who will continue to serve as Chairperson and CEO of thINc and Validation Institute.
  • "His wealth of experience and demonstrated success in driving growth aligns perfectly with our vision for the future of The Healthcare Innovation Company and Validation Institute.
  • With Sharpe's appointment, thINc and Validation Institute are poised for continued innovation, growth, and excellence in the healthcare space.

Zephyr Unveils Customized Digital Dynamic Reporting using Portfolio Performance Data

Retrieved on: 
Monday, December 11, 2023
Allocation, IPad, Wealth management, Informa, LSE, Growth, Research, Benchmarking, Digital, Software, Validation, INF, Life, Zephyr

NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Zephyr, a subsidiary of Informa plc (LSE: INF), and a recognized leader in investment management and reporting software for financial advisors and wealth managers, unveiled enhanced performance reporting capabilities allowing Zephyr software subscribers to generate custom presentations in real time using portfolio performance data.

Key Points: 
  • NEW YORK, Dec. 11, 2023 /PRNewswire/ -- Zephyr , a subsidiary of Informa plc (LSE: INF), and a recognized leader in investment management and reporting software for financial advisors and wealth managers, unveiled enhanced performance reporting capabilities allowing Zephyr software subscribers to generate custom presentations in real time using portfolio performance data.
  • "The ability to layout a customized story around investment performance using images brings strategies to life," says Zephyr's Director of Wealth Management Solutions Chris Volpe.
  • Comprehensive portfolio performance reporting addresses the growing interest in investment advice and strategies noted in the 2023 EY Global Wealth Management Research Report.
  • Jones will host Financial Storytelling: Customized Digital, Dynamic Performance Reporting, providing an overview of Zephyr's new widgets within the software on Tuesday, December 19 at 2pm ET – REGISTER NOW .

2 Day Virtual Process Validation Training Course: FDA and EU Annex 15 Qualifications and Validation - Enhance your Understanding of the Utilization of Process Validation and Phase 1, 2 and 3

Retrieved on: 
Wednesday, November 15, 2023
Transfer, Clinical trial, Comparison, Technology transfer, Continued process verification, Research, FDA, Requirements engineering, Development, Validation, Stage 2, Common, Process validation, Medical device, Cryptocurrency, Audit, Fine chemical

DUBLIN, Nov. 15, 2023 /PRNewswire/ -- The "Process Validation Training Course (FDA and EU Annex 15: Qualifications and Validation)" training has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Nov. 15, 2023 /PRNewswire/ -- The "Process Validation Training Course (FDA and EU Annex 15: Qualifications and Validation)" training has been added to ResearchAndMarkets.com's offering.
  • This seminar will provide a channel to enhance understanding of the utilization of process validation and Phase 1, 2 and 3, where their guidance blend and where they remain distinct.
  • Common questions asked by the users of Process Validation include:
    How does one integrate these two different concepts (Phase 1, 2, and 3 vs.
  • A Review of EU Annex 15 and its Comparison to FDA's Process Validation Guidance.

Advancing Quantitative Imaging: CaliberMRI, Inc. announces QIBA Conformance for Canon Medical Systems USA

Retrieved on: 
Tuesday, November 14, 2023
Magnetic resonance imaging, RSNA, Prostate, Breast, Brain, DWI, Canon Medical Systems Corporation, Liver, ADC, Magnetic resonance, Diffusion, Medical Affairs Bureau, Artificial intelligence, Machine learning, QA/QC, Validation, Standard of care, Doctor of Philosophy, MRI, Health, Medical imaging, Medical device

CaliberMRI, an industry leader in standardization of MRI, announces the successful grant of "QIBA DWI Profile Conformance Certification" to Canon Medical Systems USA (Canon Medical), a key step in integrating qMRI into clinical workflow.

Key Points: 
  • CaliberMRI, an industry leader in standardization of MRI, announces the successful grant of "QIBA DWI Profile Conformance Certification" to Canon Medical Systems USA (Canon Medical), a key step in integrating qMRI into clinical workflow.
  • CaliberMRI and Canon Collaborate to Validate AI for more efficient, reproducible quantitative MRI with RSNA/QIBA Process
    The Radiological Society of North Americas (RSNA) Quantitative Imaging Biomarkers Alliance (QIBA) has partnered with CaliberMRI to help standardize quantitative Magnetic Resonance Imaging (qMRI) to improve patient care through the QIBA Conformance Certification program.
  • We anticipate working with other Canon Medical sites and CaliberMRI on QIBA Profile Conformance to help advance qMRI."
  • "Canon Medical's approach to qMRI and QIBA Conformance is key to moving quantitative imaging to the clinic," says CaliberMRI CEO William Hollander.

Malta Inc. and Partners Win Grant From German Government

Retrieved on: 
Monday, November 6, 2023
Banking, Professional Services, Other Energy, Nuclear, Utilities, Oil, Gas, Coal, Alternative Energy, Environment, Energy, Finance, BMWK, Engineering, DLR, PTES, Government, Carbon, Wind, Electricity, Research, TESIS, Federal Ministry of Science, Technology and Innovation, Multimedia, Thermodynamics, Economy, Validation, Inc., Siemens Energy, Heat, Alfa Laval, Natural gas, Renewable energy

Malta Inc. , a world leader in long-duration energy storage (LDES), announced that its German subsidiary was awarded a grant to support a €9-million effort to accelerate the German energy transition.

Key Points: 
  • Malta Inc. , a world leader in long-duration energy storage (LDES), announced that its German subsidiary was awarded a grant to support a €9-million effort to accelerate the German energy transition.
  • View the full release here: https://www.businesswire.com/news/home/20231106500619/en/
    Germany needs to electrify its heating sector and to ensure that expanded renewable power generation is available on-demand and around-the-clock.
  • The grant will fund a technoeconomic analysis of the potential for Malta’s LDES technology to help decarbonize both electricity and heat generation in Germany.
  • “We are honored to partner with the German government and its leading national laboratory, the DLR, to explore how Malta’s technology can accelerate the transition off natural gas,” said Ramya Swaminathan, CEO of Malta.

IMVARIA Enters into Know-how Agreement with Mayo Clinic to Improve the Understanding of Cancer through AI Digital Biomarkers

Retrieved on: 
Wednesday, November 1, 2023
Oncology, Health, Technology, Health Technology, Artificial Intelligence, Biotechnology, American Cancer Society, Colon, Education, Biomarker, Prostate cancer screening, Lung cancer, MD, Research, Engineering, Death, Validation, Cancer, AI, Patient, Breast, Mayo Clinic, Medical device, Medical imaging

IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced a collaboration through a know-how agreement with Mayo Clinic to develop AI designed to significantly improve the analysis and understanding of cancer, beginning with lung cancer.

Key Points: 
  • IMVARIA Inc., a health tech company pioneering AI-driven digital biomarker solutions, today announced a collaboration through a know-how agreement with Mayo Clinic to develop AI designed to significantly improve the analysis and understanding of cancer, beginning with lung cancer.
  • The collaboration brings together IMVARIA’s engineering expertise in digital biomarkers with Mayo Clinic’s know-how and data assets as part of the Validate pillar of Mayo Clinic Platform.
  • In 2023, over 125,000 deaths have occurred due lung cancer, and nearly a quarter-of-a-million new lung cancer cases were identified.
  • Mayo Clinic will use any revenue it receives to support its not-for-profit mission in patient care, education, and research.

Validation Institute Announces Sifter Solutions Joins FoodMed Certified as Founding Member

Retrieved on: 
Thursday, November 2, 2023
CLC, Tamás Sifter, Health, LD, Science, Food, Certification, Organization, VI, Validation, Medicine, Albertsons, RDN, Founding, Patient, DNA, Medical device, Sieve

NEEDHAM, Mass., Nov. 2, 2023 /PRNewswire-PRWeb/ -- Validation Institute (VI) announced that Sifter Solutions has joined its FoodMed Certified Program as a Founding Member.

Key Points: 
  • Launched by Validation Institute earlier this year with support from other Founding Members, Albertsons Companies, Avēsis, Mom's Meals, and Uber Health, Sifter Solutions becomes FoodMed Certified's fifth Founding Member
    NEEDHAM, Mass., Nov. 2, 2023 /PRNewswire-PRWeb/ -- Validation Institute (VI) announced that Sifter Solutions has joined its FoodMed Certified Program as a Founding Member.
  • Launched by Validation Institute earlier this year with support from other Founding Members, Albertsons Companies, Avēsis, Mom's Meals®, and Uber Health, FoodMed Certified is the first certification and validation initiative for food as medicine programs.
  • FoodMed Certified by Validation Institute is a perfect match for Sifter as both organizations are committed to providing better health outcomes and savings based on data-driven analyses," said Judy Seybold, MS, RDN, LD, CLC, Chief Nutrition Officer of Sifter.
  • "We are honored that Sifter is a Founding Member of FoodMed Certified.

Vena Recognized by Ventana Research as Vendor of Merit for Second Consecutive Year

Retrieved on: 
Thursday, November 2, 2023
TCO, Research, Vena, Business plan, Microsoft, Organization, Economic and Business Research Center, Senior, Environment, Validation, Business, Ventana, Forecasting, Microsoft Excel, Completeness, Automation, Risk management, Management

TORONTO, Nov. 2, 2023 /PRNewswire/ -- Vena, the Complete Planning platform loved by finance and trusted by business, announced today it has been listed as a Vendor of Merit by Ventana Research in its 2023 Buyers Guide for Business Planning. This is the second consecutive year Vena has received this ranking, scoring its highest marks in Customer Experience, Total Cost of Ownership/Return on Investment and Validation.

Key Points: 
  • This is the second consecutive year Vena has received this ranking, scoring its highest marks in Customer Experience, Total Cost of Ownership/Return on Investment and Validation.
  • This allows companies to be proactive in their financial and operational planning, rather than reactive to changes in the economic environment.
  • "Vena distinguished itself as a standout planning provider through its dedication to meeting the expanding needs of modern FP&A professionals," said Rob Kugel, Senior Vice President and Research Director of Business Research at Ventana Research.
  • "It is an honor to again be recognized as a Vendor of Merit by Rob's team at Ventana Research," said Hugh Cumming, Chief Technology Officer at Vena.